Showing results (11-20 of 42) with videos related to
Sort By:
Pageof 5
European Journal of Nuclear Medicine and Molecular Imaging|April 30, 2025
Dual-tracer PET in prostate synovial sarcoma: discordant FDG and PSMA uptake with metastatic patternsQiaochu Chen, Lian Xu, Cheng Wang, et al.Journal of Translational Medicine|January 15, 2014
Frequent copy number variations of PI3K/AKT pathway and aberrant protein expressions of PI3K subunits are associated with inferior survival in diffuse large B cell lymphomaWenli Cui, Ying Cai, Weige Wang, et al.Chembiochem : a European Journal of Chemical Biology|January 11, 2025
NIR-II Fluorescence Imaging-guided Photothermal Activated Pyroptosis For Precision Therapy Of GliomaZhuang Chen, Yi Luo, Qian Jia, et al.International Journal of Molecular Sciences|July 13, 2024
Long-Term Remission with Novel Combined Immune-Targeted Treatment for Histiocytic Sarcoma Accompanied by Follicular Lymphoma: Case Report and Literature ReviewMinyue Zhang, Fei Xiao, Jianchen Fang, et al.BMC Medical Genomics|April 12, 2024
Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristicsBing Cao, Chenbo Sun, Rui Bi, et al.International Journal of Medical Sciences|April 15, 2024
Fatty Acid Binding Protein 1 is an Independent Prognostic Biomarker for Gallbladder Cancer with Direct Hepatic InvasionShimei Qiu, Zhaonan Liu, Jun Hu, et al.Human Pathology|August 8, 2017
Prognostic value of programmed death ligand 1, p53, and Ki-67 in patients with advanced-stage colorectal cancerLisha Wang, Zebing Liu, Kurt W Fisher, et al.Oncotargets and Therapy|January 16, 2016
Detection of lung adenocarcinoma with ROS1 rearrangement by IHC, FISH, and RT-PCR and analysis of its clinicopathologic featuresBing Cao, Ping Wei, Zebing Liu, et al.Cell Death & Disease|September 26, 2021
CHPF promotes gastric cancer tumorigenesis through the activation of E2F1Xiaolin Lin, Ting Han, Qing Xia, et al.American Journal of Cancer Research|June 24, 2015
MYBL2 is an independent prognostic marker that has tumor-promoting functions in colorectal cancerFei Ren, Lisha Wang, Xiaohan Shen, et al.Pageof 5